Los accionistas recibirán 1 acción gratis por cada 4 antiguasSpain’s National Stock Market Commission yesterday examined the prospectus submitted by Ebro Puleva for the capital increase approved at its last shareholder’s meeting. This marks the first step in a process that will culminate in Ebro Puleva’s shareholders receiving one new share for four old ones
Year: 2002
Ebro Puleva Board agrees to maintain dividend of 0.24 per share in 2003.
El 23 de Diciembre se abonará el dividendo del último trimestre de 2002The Board of Directors of Ebro Puleva has approved a dividend payment that matches last year’s, amounting to 0’24 per share. This dividend will be paid next year in quarterly instalments of 0.06 per share and corresponds to the 153.865.392 shares that will make up the company’s share capital folllowing the conclusion of the free capital increase that is presently under way, to be charged to the issue premium.
Dividend payment proposal
At its meeting yesterday, the Board of Directors of Ebro Puleva S.A. agreed to propose a dividend of ¿0.24 per share at the next Shareholder’s General Meeting. The dividend will be charged to this year’s profits and paid in four quarterly instalments of ¿0.06 per share
Other communications 29-11-2002
Press release to be issued by Ebro Puleva later on today in relation with the sale of the building located in Balmes Street in Barcelona.
Puleva Food: Analysis December 2002
Puleva Food¿s Analysis on 5 december 2002
Ebro Puleva and Ebly sign distribution agreement
Ebro Puleva, Spain’s leading food group, has signed an agreement with Ebly to distribute the French multinational company’s products in Spain.
Third-quarter results 2002
The year of consolidation. Madrid stock exchange 2002.
The year of the consolidation. Madrid stock exchange, 31 October 2002
The year of the consolidation. Madrid stock exchange, 31 October 2002.
Third quarter 2002
Quaterly preview of Puleva Biotech’s third-quarter results.
Changes in the Board of Directors
Information relative to the decisions adopted by the Board of Directors of Puleva Biotech S.A. at its meeting today.
